Surendera Tyagi

Surendera Tyagi

Corporate Officer/Principal chez
Association for Accessible Medicines
Health Technology
Consumer Services
Commercial Services

Profil

Surendera Tyagi is a Member at the Association for Accessible Medicines.
Previously, he was the Chief Scientific Officer and Global Head-R&D at Hikma Pharmaceuticals Plc from 2018 to 2019.
He was also the Vice President of the Oncology Business Unit at Fresenius Kabi Pharmaceuticals Holding LLC from 2009 to 2011.
In 2008, he was the Chief Scientific Officer at Fresenius Kabi Oncology Ltd. Dr. Tyagi received his undergraduate degree from Purdue University and his doctorate from the University of Oklahoma.

Postes actifs de Surendera Tyagi

SociétésPosteDébut
Corporate Officer/Principal -

Anciens postes connus de Surendera Tyagi

SociétésPosteFin
HIKMA PHARMACEUTICALS PLC Directeur Technique/Scientifique/R&D 01/02/2019
FRESENIUS KABI ONCOLOGY LTD Directeur Technique/Scientifique/R&D 01/12/2008
Corporate Officer/Principal -
Voir l'expérience en détail de Surendera Tyagi

Formation de Surendera Tyagi

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

29

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Surendera Tyagi